Bayesian Methods in Practice: Experiences in the Pharmaceutical Industry

DOI10.2307/2347264zbMATH Open0635.62106OpenAlexW78553138MaRDI QIDQ3774792FDOQ3774792

Author name not available (Why is that?)

Publication date: 1986

Published in: Applied Statistics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.2307/2347264

zbMATH Keywords

clinical trialsEM algorithmprobit modelBayes factorhierarchical modelprior informationpharmacokineticstwo-stage procedurecross-over designspopulation modellinghistorical informationcarryover effectsnonlinear random effects modelsacute toxicitybioequivalence assessmentprediction. LD 50 experiments

Mathematics Subject Classification ID

Bayesian inference (62F15) Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cited In (27)

• A weakly informative default prior distribution for logistic and other regression models
• Asymptotic properties of anoya bayes factors
• Clinician preferences and the estimation of causal treatment differences. (With comments)
• Bayesian index to compare assumed survival functions of two hazards following exponential distributions
• Bayesian modelling of a pharmaceutical experiment with heterogeneous responses
• On large-sample parametric approaches for interval estimation of the \(ED_{90}\)
• Hierarchical Bayesian analysis of the carryover effect in two-period crossover designs
• A Bayesian approach to Weibull survival models -- application to a cancer clinical trial
• Estimating treatment effects in clinical crossover trials
• Approximation of Bayesian predictive \(p\)-values with regression ABC
• Weak informativity and the information in one prior relative to another
• Extended Models for Quantal Response Data
• On the multivariate predictive distribution of multi-dimensional effective dose: a Bayesian approach
• Using History Matching for Prior Choice
• Constructing Release Targets for Drug Products: A Bayesian Decision Theory Approach
• Uses, Abuses and Misuses of Significance Tests in the Scientific Community: Won't the Bayesian Choice be Unavoidable?
• Bayesian methods for analysing ringing data
• Prediction markets, Bayesian priors, and clinical trials
• Bayesian tests for the balanced two-way analysis of variance model
• The Wasserstein impact measure (WIM): a practical tool for quantifying prior impact in Bayesian statistics
• Kullback-leibler information approach to the optimum measurement point for bayesian estimation
• An approach to evaluating sensitivity in Bayesian regression analyses. (With discussion)
• Critical issues in different inferential paradigms
• A Bayesian Approach for Nonlinear Regression Models with Continuous Errors
• Goodness of fit for the logistic regression model using relative belief
• Incorporating Bayesian ideas into health-care evaluation
• A Bayesian Approach to Finite Mixture Models in Bioassay via Data Augmentation and Gibbs Sampling and Its Application to Insecticide Resistance

This page was built for publication: Bayesian Methods in Practice: Experiences in the Pharmaceutical Industry

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3774792)